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= A b s t r a c t = Sometimes it is not easy to  make a diagnosis of myasthenia gravis 
(MG) when the ocular symptoms are the only clinical manifestations. The authors 
performed this study to understand the significance or the indication of repetitive 
nerve stimulation (RNS) and single fiber electromyography (SFEMG) tests in 
various stages of MG. The subjects consisted of 15 ocular, 1 2  generalized, 4 
remitted MG, and 5 other neurologic diseases which mimicked it.Positive RNS 
and SFEMG results were found in 53.3%, 86.7% of ocular type, in 0.0%, 75.0% 
of remitted type, in 75.0%, 91.7% of generalized type of MG and in 0.0%, 60.0% 
of other neurologic disease, respectively. When we analysed the results in 15 
ocular MG and in 5 non-MG groups, the RNS tests had low sensitivity (53.3%) 
and high specificity (100%) as  they were positive in 8 of 15 ocular MG, and 
negative in all of 5 non-MG group. Whereas the SFEMG had high sensitivity (86. 
7%) and low specificity (40.0%) as  it was positive in 13 of 15 ocular MG, and 
negative in 2 of 5 non-MG group.Therefore it would be concluded that the 
SFEMG test was much more sensitive than the RNS for the diagnosis of MG, but 
would not differentiate ocular MG from other neurologic diseases whose clinical 
features mimicked it. On the other hand, the diagnosis of MG would be promising 
by a positive RNS test as  its specificity was very high. 
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INTRODUCTION 
It is generally accepted that the single fiber 
electromyography (SFEMG) test is extremely 
sensitive in the diagnosis of myasthenia gravis 
(Stalberg 1974; Stalberg 1980; Emeryk et a/. 
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1985; Keesey 1989). Stalberg and Trontelj (1 979) 
reported that the diagnosis of MG could be 
abandoned if the abnormal jitter was not present 
in a weak muscle. The SFEMG tests were 
abnormal in the extensor digitorum communis 
(EDC) muscle in 26-66% of ocular MG (Sanders 
et a/. 1979; Konishi et a/. 1981 ; Sanders et a/. 
1986), and the abnormal rate cou ld  be  
increased up to 54-100% when the frontalis 
muscles were examined (Sanders et a/. 1979; 
Curz Martinez et a/. 1982), which was in good 
contrast to 19% abnormality for the repetitive 
nerve stimulation (RNS) in ocular MG (Horowitz 
et a/. 1976; Oh et a/. 1982). 
The RNS test is widely used in clinical 
neurology and helpful for the diagnosis and 
therapeutic evaluation of MG, but the clinical use 
of SFEMG is limited since abnormal findings are 
found in various neuromuscular diseases, 
inc luding MG, Eaton-Lambert syndrome, 
myopathy, and neuropathy etc (Stalberg 1979; 
Oh 1988). Oh et a/.  (1992) reported that the 
SFEMG was needed in only 9% of MG when the 
SFEMG was recommended if the RNS and AchR 
antibody tests were normal. Not infrequently the 
cl inician confro,nt's patients whose cl inical 
features mimic those of ocular MG, but are not 
suggestive of definite MG and refers them to the 
electromyographer for the differential diagnosis. 
Therefore in this study the authors performed the 
RNS and SFEMG tests in 31 MG and 5 non-MG 
to understand the significance of RNS and 
SFEMG for the diagnosis of MG and to clarify the 
indication and interpretation of SFEMG tests for 
evaluating ocular MG and borderline non-MG. 
METHOD AND MATERIALS 
The RNS and SFEMG tests were studied In 
31 MG and 5 non-MG neurological diseases 
which mimicked the clinical features of ocular 
MG. The data from RNS and SFEMG were 
analysed in different types of MG, that is, 15 
ocular, 4 remitted, and 12 generalized MG, and 
compared with those in 5 non-MG neurological 
cases. Finally the diagnostic sensitivity and 
specif ic i ty of RNS and SFEMG tests were 
calculated in limited MG subjects and in non-MG 
subjects, respectively. 
The diagnosis of MG was made by a 
combination of clinical features and several 
laboratory work-ups, involving clinical response 
to anticholinesterase agents,  decremental 
response to repetitive stimulation, the presence 
of acetylcholine' receptor antibodies, negative 
imaglng studies, and thyroid function studies 
(Kim et a1 1991 : Lee et a/. 1992). Those 31 MG 
subjects were followed up at a minimum 6 
months and there was no evidence for the 
presence of another condition that could explain 
the weakness. Also the severity of MG was 
graded according to the modified Osserman's 
classif icat ion. The RNS and SFEMG were 
performed at the t ime of MG evaluat ion 
regardless of the condit ion of therapeutic 
regimens. 
The 5 non-MG group initially showed clinical 
features which mimicked those of MG.  4 
subjects complained of ocular symptoms, 
referred sequentially to the EMG laboratory for 
the diagnosis or exclusion of MG. They were 
followed up from 4 to 12 months and classified 
as "non-MG neurological d isease" .  The 
remaining one subject complained of easy 
fatigability without any ocular symptoms, and the 
final diagnosis was "Eaton-Lambert syndrome" 
associated with non-small cell lung carcinoma. 
RNS a n d  S F E M G  t e s t s  a n d  
in te rpre ta t  i o n  
The RNS test was performed on the 
abductor digiti quinti (ADQ) and orbicularis oculi 
( 0 0 )  muscles with stimulating electrodes at the 
wrist on the ulnar nerve and near the facial nerve 
just distal to its exit from the stylomastoid 
foramen, respectively (Oh et a/. 1982). Six 
responses were obta ined at low rate of 
stimulation (LRS) 2 per, 3 per, and 5 per second, 
and followed by the high rate stimulation (HRS) 
of 50 per second for one second, according to 
the protocol in our EMG laboratory. 
To calculate the decremental response, the 
authors measured the peak-to-peak amplitude of 
the first and the lowest CMAP among the six and 
expressed as a percentage of the first CMAP by 
the following formula: 
1 st CMAP-designated CMAP 
I st CMAP 
x 100 
= decrement (%). When decremental response 
was more than the mean value plus two standard 
deviation, the result was considered abnormal 
(Ekstedt and Stal berg 1973; Ekstedt et a/. 1974). 
The SFEMG was performed on the extensor 
digitorurn communis (EDC) muscle following the 
standard method (Stalberg 1974; Kimura 1983; 
Oh 1988) using the satellite EMG machine 
Nicolet Pathfinder II. The patient assumed a 
supine position on the examining table and was 
taught to sustain minimal EDC muscle 
contraction. Then the special SFEMG needle 
would record single or double EMG potentials by 
careful movements of the needle. Once the 
double potentials were obta ined,  eight 
superimpositions were recorded. The authors 
tried to record at least 50 discharges for each 
pair. 
The jitter was best expressed as the mean 
value of consecutive interpotential differences 
(MCD) and was calculated by'manual method 
as shown in Fig. 1 (Stalberg 1974). At identical 
points on the fast negative deflection, the 
latency difference was measured between the 
earliest and latest second slave potentials. This 
time range of 8 discharges (R8) was collected 
and converted to estimated MCD by multiplying 
by a conversion factor of 0.40 (Table 1). The 
manually estimated MCD value was said to be in 
a good approximation to the actual MCD which 
was calculated using a computer program 
(Mihelin et a/. 1975). The SFEMG test was 
considered abnormal when either of the 
following criteria were met; (1) the mean MCD 
was longer than 36 ktsec, (2) individual MCD 
was greater than 54 psec. 
RESULTS 
Among 31 MG, there were positive RNS 
tests 5 in 17 (54.8%) and positive SFEMGs in 27 
(87.1%). When we divided the data of the RNS 
and SFEMG tests according to the clinical 
severity of MG, positive RNS and SFEMG tests 
were found in 53.3%, 86.7% of ocular MG, in 0. 
O0l0, 75.0% of remitted MG and in 75.0%, 91.7% 
of generalized MG, respectively (Table 3). 
The SFEMG showed positive results in the 
majority of MG subjects (N=27), regardless of 





Fig. 1. The SFEMG in case 26 showed normal (A) 
and abnormal (B) action potential pair. The 
calculated mean MCD value in A and B was 
40 .0  psec and 84.2 psec, respectively by 
multiplying a conversion factor (R8=0.40) to the 
measured latency difference 60.5 psec (A) and 
210.6 psec (B). 
Table 1. Conversion factors for calculation of MCD 
- - - - - 
n 2 3 4 5 6 7 8 9 1 0  
F, 1.0 0.67 0.55 0.49 0.45 0.42 0.40 0.38 0.37 
- - --- -- -- - - ~ 
MCD: Mean value of consecutive interpotential 
differences 
MCD = R, n F,, where n represents number of 
superimposed sweeps, F, is the conversion factor, and 
R, is the measured mean value of jitter. 
negative ( N = l  1 j .  The SFEMG result was also 
negative in those subjects of ocular (case I ) ,  
remitted (case 28), and generalized MG (case 
5), who showed negative RNS. But one ocular 
MG subject (case 9) showed a negative SFEMG, 
even though the RNS was posit ive in the 
orbicularis oculi muscle (Table 2). 
In all 5 subjects of the non-MG group, the 
RNS showed negative results in the ADQ and 
orbicularis oculi muscle. The SFEMG was 
positive in two and negative in the other two 
subjects, who showed clinical features similar to 
ocular MG. But in case 33 who was diagnosed 
to have Eaton-Lambert syndrome by the 
characteristic electrophysiological features, the 
mean MCD was markedly increased up to 52.0 
psec (Table 3).  Thus in the non-MG group 
positive RNS and SFEMG tests were found in 
0.0%, 60.0%, respectively. 
When the RNS and SFEMG tests were 
evaluated in limited groups of the ocular MG and 
non-MG groups of other neurological diseases, 
the RNS showed low sensitivity (53.3%) and high 
specificity (100.0%) as it was positive in 8 of 15 
ocular MG and negative in all of the 5 non-MG 
group. But the SFEMG showed high sensitivity 
(86.7%) and low specificity (40.0%) as it was 
positive in 13 of 15 ocular MG, and negative in 2 
of 5 non-MG group (Table 4). 
The SFEMG test was much more sensitive in 
diagnosis of MG than the RNS, as shown in table 
3. There was no significant difference of positive 
SFEMG ratio among ocular, remitted, and 
generalized MG, being positive in 86.7%, 75.0%, 
91.7%, respectively (figure 2). Even though the 
positive SFEMG was found in about 60.0% of 
non-MG group, the value of mean MCD was 
small in the non-MG group, compared with that 
in MG groups (Fig. 2). 
Table 2. Data of repet~t~ve nerve st~mulat~on and s~ngle flber electromyography In 31 myasthenla gravls and 5 
non-myasthenla gravls 
- - -- - - - -- - 
RNS SFEMG RNS SFEMG 
Cases Clln~cal - Case Cl~n~cal 
features ADQ 00 mean MCD features ADQ 00 mean MCD 
- -- -- - - - - 
1 I - - 24 3 - 19 I IA + + 109 6 + 
2 116 + + 98 3 + 20 R - 45 0 + 
3 I + 82 6 + 2 1 I - + 93 8 + - 
4 I ~ B  - + 38 7 + 2 2 I - - 42 3 + 
5 IIA - - 33 3 - 2 3 I - + 72 5 + 
6 I + 44 5 + 24 IIP - - 52 0 + - 
13. I I A  - - 107.5 + 31. 1 I A + + 67.0 + 
14. I - - 47.9 + 32, non-MG - - 28.3 - 
15. I IA - + 59.2 + 33. E LS - - 52.0 + 
16. R - - 41.0 + 34, non-MG - - 22.9 - 
17. I - - 42.1 + 35. non-MG - - 46.0 + 
18. 116 - + 187.5 + 36. non-MG - - 40.6 + 
-- - - - - -- p~ - ~ - ~ . - - - -- 
ADQ: abductor digiti quinti, 00: orbicularis oculi, MCD: mean value of consecutive interpotent~al differences, 
+: positive results, -: negative results 
Table 3. Comparison of repetitive nerve stimulation 
and single fiber electromyography tests 
RNS Tesrs 
Types OF MG SFEMG 
on ADQ on 00 on EDC 
Ocular MG 2(13.3%) 8(53.3%) 13(86.7%) 
(N= 15) 
Rem~tted MG O( 0.0%) O( 0.0%) 3(75 0%) 
(N=4) 
General~zed MG 4(33.3%) 9(75.0%) 1 1(91.7%) 
(N=12) 
All MG(N=31) 6(19.4%) 17(54.8%) 27(87.1%) 
EDC: extensor digiti quinti 
Table 4. Comparison of repetitive nerve stimulat~on 
and single fiber electromyography between 
ocular MG and other neurological diseases 
Positive RNS* Positive SFEMG** 
Ocular MG(N= 15) 8(53.3%) 1 3(86.7%) 
Other neurological 
dlseases(N=5) O( 0.0%) 3(60.0%) 
* RNS: low sensitivity (53.3%), high specificity (100%) 
* *  SFEMG: high sens~tivity (86.7%), low specificity (40.0%) 
DISCUSS ION 
It is often not easy to make a diagnosis of 
MG on cl inical  grounds.  Usually the 
characteristic clinical features of MG would be 
the typical distr ibut ion of ocular,  facial ,  
oropharyngeal or limb muscle weakness, the 
fluctuating nature of the weakness dur~ng the 
day or hours, and the clinical improvement by 
the administration of anticholinesterase agents 
(Penn and Rowland 1989). Thus an unequivocal 
positive edrophonium test has been thought to 
be crucial. However the edrophonium test shows 
low sensitivity, especially in ocular MG and false 
positive results in various diseases ~ncluding 
neuromuscular disease. 





Ocular MG Rern~tted MG Generalized MG Other disease 
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Fig. 2. The distribution of mean MCD in 31 MG and 5 
non-MG groups revealed no signif icant 
difference among various types of MG. 
However the abnormal mean MCD value was 
very small in these non-MG, compared with 
those values in MG subjects. 
improved using several laboratory tests, the 
serum acetylcholine receptor antibody (AChR- 
Ab) assay, the repetitive nerve stimulation (RNS), 
and the single fiber electromyography (SFEMG). 
Oh et a/. (1992) reported that at least one of 
AChR-Ab assay, the RNS test, and the SFEMG 
test was abnormal in all 120 cases of MG, and 
the SFEMG was most sensitive in the diagnosis 
of MG. However the report did not say how the 
diagnosis of MG was established or what 
proportions of different severity of MG were 
involved. 
In our study the diagnosis of "definite MG" 
was established if the following criteria were met; 
( 1 )  there was fluctuating weakness of ocular, 
extraocular, facial, oropharyngeal and/or limb 
muscles which were compatible with MG, (2) 
clear improvement on anticholinesterase was 
documented by the physician and reported by 
the patient which was sus~ained for at least three 
months, (3 )  there was no evidence of the 
presence of another condition that could explain 
the clinical symptoms. However we did not 
establish a final diagnosis in these subjects in 
the non-MG group, except for one with Eaton- 
Lambert syndrome. These 4 subjects did not 
show any clinical features suggestive of ocular 
MG and d id  not fulfi l l the aforementioned 
diagnostic criteria of MG during the six months 
follow-up period. So we could say that we ruled 
out other diagnosis, such as thyroid 
opthalmopathy, subt le brainstem infarcts, 
multiple sclerosis, or mitochondria1 myopathy 
etc, even though definite diagnoses were not 
made. 
Our study showed that the SFEMG was 
much more sensitive than the RNS, even though 
each test revealed a higher percentage of 
positive results in generalized MG than in ocular 
MG. The RNS test in the ADQ muscle was 
nonproductive, showing positivity in 2 of 15 
ocular MG (13.3%), which was compatable with 
various reported data (Horowitz et a1 1976; 
Krarup 1977; Oh et al. 1982). But the diagnostic 
sensitivity of RNS was higher in the orbicularis 
oculi in ocular MG (53.3%). According to Oh's 
data, a higher yield (64%) in the RNS test was 
noted in the orbicularis oculi due to their unique 
technique. Thus RNS on the proximal muscle is 
often recommended to increase the diagnostic 
sensitivity when the RNS on distal muscles 
shows negative results (Ozdemir et a/.  1976). 
On the contrary, the SFEMG was very 
sensitive in ocular (86.7%), generalized (91.7%), 
and remitted MG (75.0%). The normal mean 
MCD (less than 36 psec) was found in 2 ocular, 1 
remitted, and 1 generalized MG. It was not an 
unusual finding because the SFEMG test was 
performed only in EDC muscles in those 
patients. The diagnostic sensitivity became high 
up to 54-100% when the frontalis muscle was 
also examined in ocular and generalized MG 
(Stalberg et al. 1974; Jablecki 1978; Sanders et 
al. 1979; Curz Martinez 1982). Stalberg and 
Trontelj (1979) said that they could rule out the 
diagnosis of MG if the increased jitter was not 
found in weak muscle. 
Our results for positive SFEMG in ocular MG 
were high (86.7%), compared with previously 
reported data of Stalberg and Sanders (1981), 
Cruz Martinez etal .  (1982), Sanders and Howard 
(1 986). Sunwoo ( 1  988), being 59%, 66%, 57%. 
88%, respectively. It could be possible that some 
of those subjects classified into ocular MG might 
have subclinical limb weakness or a long hrstory 
of ocular MG. The SFEMG technique and 
interpretation could be other factors because 
this test requires fairly elaborate equipment and 
patient cooperation. 
As shown in table 2,  the SFEMG was 
positive in the majority of MG subjects when they 
showed positive RNS (N=6) or negative RNS 
( N = l l ) .  In case 9, the mean jitter was 34.7 psec 
and the RNS was positive in the orbicularis oculi 
muscle.  This patient had complained of 
intermittent diplopia for several years and was 
unlikely to require treatment. The data in this 
patient supported Sanders et a / .  s report that 
they increased the positive rate of SFEMG from 
38% on EDC to 100% on frontalis muscles in 13 
cases of ocular MG (Sanders et a / .  1979; 
Sanders and Howard 1986). In this connection, it 
is a good idea that the SFEMG should be 
performed in a weak muscle such as the frontalis 
when the test did not show abnormal jitter on 
EDC muscles, especially in ocular MG. 
In the non-MG group the RNS and the 
SFEMG tests showed positrve results in none 
(0%) and in 3 (60.0%) of 5 subjects, respectively. 
Rouseev et al. (1992) reported that they found 
abnormal SFEMG in 6 of 18 patients with a 
"def ini te other diagnosis" ( 33 .3%) ,  and 
concluded that the abnormality might be rather 
mild, compared with that In "definite MG". 
When we analysed the data of ocular MG 
(N=15), and non-MG (N=5) groups, the RNS 
showed low sensitivity ( 53 .3%)  and high 
specificity (lOOO/o) and the SFEMG showed high 
sensit~vity (86.7%) and low specificity (40.0%). 
Roussev et a/ .  (1992) also reported the results 
similar to our data, in which they used as 
abnormal SFEMG criteria 2 or more palrs of 20 
with jitter > 45 psec, or mean jitter > 34 psec, 
and maximized the sensitivity and specificity of 
the SFEMG tests for "definite ocular" MG from 
other cond~t ions causing ocular symptoms. 
Further they concluded that it was possible to 
predict that i f  the test IS abnormal, the patient 
has ocular MG and is likely to require therapy, or 
if the test is normal, the patient has some other 
condition, or has mild ocular MG that is unlikely 
to require medication. When they improved the 
specificity by taking the criteria to mean jitter 
greater than 50 psec .  But there was no 
significant difference of abnormal mean MCD 
value among different severities of MG in our 
study (Fig. 2). 
The RNS test has also several advantages 
e.g., relative simplicity, rapid results, and a good 
correlation between electrophysiological and 
clinical assessment of disease severity in MG, 
even though its sensitivity is low. Oh et a/. (1992) 
said the RNS on proximal muscles was 
recommended to increased the diagnostic yield 
by 15%. 
In conclusion, the authors believe that RNS 
and SFEMG have unique value for the diagnosis 
of MG. The RNS would be recommended to be 
done in those patients suspected of MG on the 
ADQ and orbicularis oculi muscles first. The 
diagnosis of MG could be confirmed if the RNS 
test was positive. If the RNS is normal even in 
the proximal muscle, SFEMG is needed. It is said 
that SFEMG is indicated in only limited numbers 
of suspected MG (9%) when we follow the 
testing guideline. 
If the SFEMG is positive in first the EDC or 
second the frontalis muscle. the diagnosis of MG 
may be possible, but not confirmative because 
its specificity is very low, especially in those 
patients with ocular symptoms. In this situation, it 
could be the most important step that we can 
identify the classical SFEMG pattern in MG, 
characterized by, (1) definite increased jitter with 
or without neuromuscular b locking,  (2 )  
increasing jitter abnormality with a higher 
discharge rate, and (3) normal fiber density 
(Schwartz and Stal berg 1975). 
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